Direkt zum Inhalt
Merck
  • Synthesis of stable isotope labelled internal standards for drug-drug interaction (DDI) studies.

Synthesis of stable isotope labelled internal standards for drug-drug interaction (DDI) studies.

Bioorganic & medicinal chemistry (2012-08-15)
J Atzrodt, J Blankenstein, D Brasseur, S Calvo-Vicente, M Denoux, V Derdau, M Lavisse, S Perard, S Roy, M Sandvoss, J Schofield, J Zimmermann
ZUSAMMENFASSUNG

The syntheses of stable isotope labelled internal standards of important CYP-isoform selective probes, like testosterone 1, diclofenac 3, midazolam 5, and dextromethorphan 7, as well as their corresponding hydroxylated metabolites 6β-hydroxytestosterone 2, 4'-hydroxydiclofenac 4, 1'-hydroxymidazolam 6 and dextrorphan 8 are reported. Microwave-enhanced H/D-exchange reactions applying either acid, base, or homogeneous and heterogeneous transition metal catalysis, or combinations thereof proved to be highly efficient for direct deuterium labelling of the above mentioned probes. Compared to conventional stepwise synthetic approaches, the combination of H/D exchange and biotransformation provides the potential for considerable time- and cost savings, in particular for the synthesis of the stable isotope labelled internal standards of 4'-hydroxydiclofenac 4 and 1'-hydroxymidazolam 6.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Supelco
α-Hydroxymidazolam -Lösung, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
1′-Hydroxymidazolam
Supelco
α-Hydroxymidazolam -Lösung, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®